Cypress Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Sell |
15,325
-209
| -1% | -$38.8K | 0.83% | 23 |
|
|
2025
Q1 | $3.25M | Buy |
15,534
+292
| +2% | +$61.2K | 0.94% | 17 |
|
|
2024
Q4 | $2.71M | Sell |
15,242
-156
| -1% | -$27.7K | 0.77% | 21 |
|
|
2024
Q3 | $3.04M | Sell |
15,398
-1,185
| -7% | -$234K | 0.78% | 20 |
|
|
2024
Q2 | $2.84M | Sell |
16,583
-4,588
| -22% | -$787K | 0.71% | 22 |
|
|
2024
Q1 | $3.86M | Sell |
21,171
-493
| -2% | -$89.8K | 1.05% | 15 |
|
|
2023
Q4 | $3.36M | Buy |
21,664
+214
| +1% | +$33.2K | 0.96% | 17 |
|
|
2023
Q3 | $3.2M | Sell |
21,450
-680
| -3% | -$101K | 0.94% | 15 |
|
|
2023
Q2 | $2.98M | Buy |
22,130
+471
| +2% | +$63.5K | 0.86% | 13 |
|
|
2023
Q1 | $3.45M | Sell |
21,659
-2,621
| -11% | -$418K | 1.08% | 12 |
|
|
2022
Q4 | $3.92M | Buy |
24,280
+75
| +0.3% | +$12.1K | 1.23% | 11 |
|
|
2022
Q3 | $3.25M | Buy |
24,205
+534
| +2% | +$71.7K | 1.14% | 11 |
|
|
2022
Q2 | $3.63M | Sell |
23,671
-3,327
| -12% | -$510K | 0.52% | 38 |
|
|
2022
Q1 | $4.38M | Buy |
26,998
+183
| +0.7% | +$29.7K | 0.54% | 38 |
|
|
2021
Q4 | $3.63M | Buy |
26,815
+279
| +1% | +$37.8K | 0.41% | 43 |
|
|
2021
Q3 | $2.86M | Buy |
26,536
+510
| +2% | +$55K | 0.36% | 45 |
|
|
2021
Q2 | $2.93M | Buy |
26,026
+1,895
| +8% | +$213K | 2.86% | 4 |
|
|
2021
Q1 | $2.61M | Buy |
24,131
+879
| +4% | +$95.1K | 1.07% | 13 |
|
|
2020
Q4 | $2.49M | Sell |
23,252
-351
| -1% | -$37.6K | 1.13% | 12 |
|
|
2020
Q3 | $2.03M | Sell |
23,603
-2,587
| -10% | -$223K | 0.94% | 13 |
|
|
2020
Q2 | $2.57M | Buy |
+26,190
| New | +$2.57M | 1.14% | 13 |
|